MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Repetitive transcranial magnetic stimulation (rTMS) for the treatment of pain in Parkinson’s Disease – an open-label study

    M. Bonello, T. Nurmikko, A. Mavrianou, M. Steiger (Liverpool, United Kingdom)

    Objective: To investigate the safety and efficacy of rTMS in the treatment of Parkinson’s Disease associated pain. Background: Pain is a prevalent symptom in patients…
  • 2019 International Congress

    Actigraphically Characterized Infradian Rest-Activity Rhythms in Parkinson’s Disease

    C. Brooks, R. Koehler, MK. Erb, F. Mortazavi, J. Bhangu, K. Thomas (Boston, MA, USA)

    Objective: To characterize infradian variations across the week in participants with Parkinson’s disease (PD), preliminary analyses were conducted as a means to develop a process…
  • 2019 International Congress

    The prevalence and features of REM sleep behaviour disorder in Essential Tremor: a polysomnography study

    P. Bugalho, M. Salavisa, C. Borbinha, M. Fernandes, B. Meira, R. Barbosa, M. Mendonça (Lisboa, Portugal)

    Objective: To assess the prevalence and characteristics of video-polysomnography (PSG) confirmed REM sleep behaviour disorder (RBD) in patients with Essential Tremor (ET). Background: ET has…
  • 2019 International Congress

    Health associated quality of life (HAQL) and humor/cognitive complaints predict mortality in Parkinson’s disease (PD)

    P. Bugalho, R. Barbosa, F. Ladeira, J. Marto, C. Borbinha, L. Conceição, M. Saraiva, M. Salavisa, B. Meira, M. Fernandes (Lisbon, Portugal)

    Objective: To assess the value of motor (MS), non-motor symptoms (NMS), HAQL and activities of daily living (ADL) for predicting mortality in PD. Background: Parkinson’s…
  • 2019 International Congress

    Anxiety and dopaminergic stimulation in patients with Parkinson´s disease.

    A. Camacho Nieto, AR. Franco Salinas, L. Ruiz-Escribano Menchen, MJ. Gallardo Alcañiz, JP. Cabello Rosa, J. Vaamonde Gamo (Ciudad Real, Spain)

    Objective: To report two patients with Parkinson disease and describe the response of this non motor symptom to dopaminergic therapy. Background: Anxiety is frequent comorbidity…
  • 2019 International Congress

    Longitudinal Cortical Changes Associated with Apathy in Parkinson’s Disease

    E. Canu, F. Agosta, F. Imperiale, T. Stojković, I. Stankovic, S. Basaia, A. Fontana, V. Markovic, I. Petrović, E. Stefanova, V. Kostic, M. Filippi (Milan, Italy)

    Objective: To follow clinical/cognitive and cortical thickness (CT) changes in Parkinson’s disease (PD) patients with stable apathy (PD-sAp), without apathy (PD-noAp), and patients who developed…
  • 2019 International Congress

    Deceleration capacity of heart rate: is cardiac vagal modulation impaired in idiopathic Parkinson’s disease?

    C. Carricarte Naranjo, C. Marras, N. Visanji, D. Cornforth, L. Sanchez-Rodriguez, B. Schüle, S. Goldman, M. Estevez, P. Stein, A. Lang, H. Jelinek, A. Machado (La Habana, Cuba)

    Objective: Assessment of cardiac vagal modulation through the analysis of heart rate deceleration capacity (DC) in idiopathic Parkinson’s disease (PD). Background: Cardiac autonomic dysfunction manifests…
  • 2019 International Congress

    (Not) sleeping with the enemy: Cognitive correlates of nocturnal sleep disturbances in Parkinson’s disease

    S. Castillo-Torres, C. Cerda-Contreras, D. Roque-Martínez, D. Díaz-Pérez, X. Ortiz-Jiménez, B. Chávez-Luévanos, I. Estrada-Bellmann (Monterrey, Mexico)

    Objective: To evaluate cognitive correlates of nocturnal sleep dysfunction in patients with idiopathic Parkinson’s disease (PD). Background: Sleep disturbances are among the most troublesome and…
  • 2019 International Congress

    Characterization of the gastrointestinal dysfunction in the 6-hydroxydopamine rat model of Parkinson’s disease

    X. Chai, S. Diwakarla, R. Pustovit, R. Mcquade, M. Di Natale, C. Ermine, C. Parish, D. Finkelstein, J. Furness (Melbourne, Australia)

    Objective: To characterize the gastrointestinal (GI) phenotype in the 6-hydroxydopamine (6OHDA) rat model of Parkinson’s disease (PD). Background: GI dysfunction, such as prolonged GI transit…
  • 2019 International Congress

    Olfactory Hallucinations as a Non-motor sign of Parkinson’s disease- a cross sectional study

    S. Chandra, M. Schiess, R. Mehanna (Houston, TX, USA)

    Objective: To describe the prevalence and characteristics of Olfactory Hallucinations (OlfH) in patients with Parkinson’s Disease (PD) in a tertiary movement clinic. Background: Hallucinations are…
  • « Previous Page
  • 1
  • …
  • 1382
  • 1383
  • 1384
  • 1385
  • 1386
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley